Puma Biotechnology, Inc.'s (NASDAQ:PBYI) US$24m market value fall may be overlooked by institutional investors after a year of 1.6% returns - Simply Wall St News
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology Reports Third Quarter 2022 Financial Results | Business Wire
Puma Biotech's (PBYI) Breast Cancer Drug Nerlynx Aids Growth
Can Puma Biotechnology Inc (PBYI) Stock Rise to the Top of Healthcare Sector Tuesday?
Puma Bio Stock: Still Worthy After Earnings Surprise (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Surging
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology - Crunchbase Company Profile & Funding
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Puma shares nearly triple on drug news, but options smell 'fishy'
Why Puma Biotechnology, Inc. Stock Soared 65.1% in July | Nasdaq
Goldman Sachs Group Cuts Stake in Puma Biotechnology (PBYI)